September 20, 2024

High-Dose Vitamin D3 Does Not Provide Benefit for Metastatic Colorectal Cancer

Researchers evaluated the addition of high-dose vitamin D3 to standard treatment for metastatic colorectal cancer. They presented their findings at the ESMO Congress 2024.

The ASCO Post

September 12, 2024

Association of Body Mass Index and Risk of Colorectal Cancer and Related Mortality in Asia

In a study reported in JAMA Network Open, Paragomi et al found that higher body mass index (BMI) was associated with increased risk of incident colorectal cancer and colorectal cancer–related mortalit...

The ASCO Post

February 15, 2024

Do Patients With Molecular MRD Detected After Colorectal Cancer Surgery Benefit From Adjuvant Chemotherapy?

Circulating tumor DNA may be used to detect molecular MRD in patients who underwent surgery for colorectal cancer and to determine whether they may benefit from receiving adjuvant chemotherapy. The re...

The ASCO Post

June 23, 2023

Expert Point of View: Lisa Newman, MD, MPH, FACS, FASCO

Dr. Lisa Newman emphasizes the critical relevance of including diverse populations in clinical genomic profiling for colorectal cancer, shedding light on potential missed opportunities in homogeneous population studies.

The ASCO Post

August 02, 2023

Gastrointestinal Symptoms May Be Prevalent in Geriatric Female Colorectal Cancer Survivors

About 80% of geriatric female colorectal cancer survivors may experience a range of gastrointestinal symptoms years after receiving a diagnosis and treatment for their tumors, according to a recent st...

The ASCO Post

November 13, 2023

FDA Approves Fruquintinib for Refractory Metastatic Colorectal Cancer

On November 8, the FDA approved an anti-VEGF tyrosine kinase inhibitor for adult patients with metastatic colorectal cancer who received prior fluoropyrimidine-, oxaliplatin-, and irinotecan-based che...

The ASCO Post

January 24, 2024

Study Finds Majority of Patients With Lynch Syndrome Are Not Using Aspirin to Reduce Risk of Colon Cancer

In the PREVENTLynch study, investigators assessed the prevalence of aspirin use as a protective measure against colon cancer among patients with Lynch syndrome.

The ASCO Post

March 28, 2024

Stage III Colorectal Cancer: Association of Immunoscore With Disease-Free Survival

In an analysis of two trials (SCOT and IDEA-HORG), investigators identified the predictive value of Immunoscore for disease-free survival in patients with stage III colorectal cancer treated with adju...

The ASCO Post

March 10, 2023

Expert Point of View: Aparna R. Parikh, MD

Dr. Aparna R. Parikh, an expert in cancer care, shared insights on the C-800 study, highlighting the lack of progress in MSS colorectal cancer and the difference in efficacy in patients with and without liver metastases.

The ASCO Post